Basaglar

Showing all 2 results

What is Basaglar?

The insulin glargine used in Basaglar (insulin glargine) is a long-acting insulin that begins working several hours after injection and keeps working continuously for 24 hours. Insulin lowers blood sugar levels by reducing the level of glucose in the blood.

Among adults and children who have diabetes mellitus, basaglar improves blood sugar control.

The drug is prescribed to adults and children with type 1 diabetes (not type 2) at least six years old.

Diabetes type 1 patients use Basaglar KwikPen in conjunction with short-acting insulin before eating.

Warnings

If the needle has been changed on a Basaglar KwikPen, do not share it with anyone else.

If you experience hypoglycemia or diabetic ketoacidosis, you should consult your doctor.

Basaglar is just one component of a comprehensive program that may include a healthy diet, physical exercise, weight control, foot care, eye care, dental care, and testing for diabetes. Having a balanced diet and taking the right supplements, as well as exercising, is very important. You could potentially alter your blood sugar levels by changing these factors.

Even if the needle is changed, never share an injection pen.

Basaglar Side Effects

In case of an allergic reaction to Basaglar, seek immediate medical attention if you experience any of the following symptoms: redness, swelling, itchy rash, fast heartbeats, feeling as if you may collapse, swelling in your throat or tongue.

Notify your healthcare provider if you have:

– An increase in weight or swelling in your feet or ankles;
– trouble breathing; or
constipation, leg cramps, irregular heartbeats, fluttering in the chest, increased thirst or urination, numbness, muscle weakness, or a limp feeling are symptoms of low blood potassium.

Common Basaglar side effects may include:

– Hypoglycemia;
– increased weight; swelling;
– itching, rash; or allergic reaction
– You will notice a thinned or hollowed area of skin where you have injected the medication.

Other side effects may occur, and this is not a complete list. Speak to your doctor if you experience any side effects. FDA can be contacted at 1-800-FDA-1088 if you experience any side effects.

People with an allergy should not use Basaglar KwikPen to insulin or experience hypoglycemia (low blood sugar) or diabetic ketoacidosis (consult your doctor).

Some brands of KwikPen are for adults only, and Basaglar KwikPen should not be used by children younger than six years old. Children of any age should not be treated for type 2 diabetes with this medicine.

Tell your doctor if you have any of these conditions to make sure Basaglar is safe for you:

– If you have liver or kidney disease

– If you have any signs of heart failure or other heart problems.

You should also let your doctor know if you are taking pioglitazone or rosiglitazone (often in conjunction with glimepiride or metformin). You may be considered more likely to suffer serious heart problems if you take certain diabetes drugs while using insulin.

Pregnant or breastfeeding women should tell their doctors.

If you become pregnant, consult your doctor before using this medicine. During pregnancy, it is vital to maintain a healthy blood sugar level.

Basaglar KwikPen: How do I use it?

Follow your doctor’s instructions exactly when taking Basaglar. Take Basaglar in the recommended dose and for the recommended length of time.

Follow all instructions on the packaging. Your pharmacist or doctor can assist you with any questions you may have.

Insulin glargine of the Toujeo brand contains three times more insulin per milliliter (mL) than insulin glargine of the Basaglar brand. Toujeo includes 300 units of insulin, and Basaglar includes 100 units.

Your dosage requirements may change if you change your insulin’s type, brand, or strength.

The medication is injected into the skin. Injections are administered at home. It is essential to acknowledge the proper use of the injection and disposal of used needles and pens before taking Basaglar.

It is not advisable to mix Basaglar with insulin pumps or other insulins. A vein or muscle should not be injected with Basaglar.

Before receiving medications, the skin must not be damaged, bruised, pitted, thickened, scaly, scarred, or lumpy.

The drug is usually injected simultaneously every day at a daily dose of once a day. It can be administered at home. If you do not properly dispose of needles and pens, you should not inject yourself with this medicine.

You will be shown the best places to inject Basaglar on your body by your healthcare provider. Each time you inject Basaglar, place it on a different part of your body. Avoid injecting it twice in the same area.

Basaglar KwikPen must be used with the injection pen that comes with it. Replace the needle after each use. Transferring insulin from the cell to a syringe is not recommended.

Injection pens should never be shared, even if the needle has been changed. If these devices are shared, it is possible to pass on infections or diseases from one person to another.

Do not share needles. Dispose of used pens following local laws. You can dispose of sharps in a puncture-proof container (ask your pharmacist where to get one and how to dispose of it). Be mindful that pets and children cannot reach this container.

In addition to hunger and dizziness, hypoglycemia can cause confusion, irritability, anxiety, and shaking. Hypoglycemia can be treated quickly by eating or drinking fast-acting sources of sugar.

Glucagon injection kits may be prescribed by your doctor if you suffer from severe hypoglycemia.

If you need this injection in an emergency, make sure your family or friends know how to administer it.

Monitor for signs of hyperglycemia (high blood sugar), such as increased thirst or urination.

Several factors can affect blood sugar levels, including stress, illness, surgery, exercise, alcohol consumption, and skipping meals. Before adjusting your insulin schedule, speak to your doctor first.

In addition to basaglar, diet, exercise, weight control, blood sugar testing, and special medical care are all part of a treatment program. Following your doctor’s instructions closely is essential.

Basaglar should be stored away from the sun and heat from its original container. Refrigeration’s cooling element should not be used to freeze or store insulin. After storing or freezing insulin, it should be disposed of.

The medicine should not be used if the color or particles have changed or the drug appears cloudy. 

You can wear an ID card (or a diabetes medical alert tag) in case of an emergency. You should notify any medical care providers who treat you with diabetes.

Injectors with needles attached should not be stored. Syringes and needles should not be reused. If you dispose of them in your state or local law, you should place them in a puncture-proof “sharps” container. Pets and children should not be able to gain access to the mediation.

Storage

Storage of unused Basaglar KwikPens:

– Keep in the refrigerator until they expire; or
– use within 28 days if stored at room temperature.

Opening and holding the Basaglar KwikPen:

– During the first 28 days after purchase, the injection pen should be kept at room temperature (not refrigerated).

FAQ of Basaglar

How are Basaglar and Lantus different?

Basedaglar and Lantus are long-acting insulin injections that contain insulin glargine. This form of insulin helps people with type 1 and type 2 diabetes control blood sugar levels. The insulin starts working several hours after injection and keeps working steadily over 24 hours. Sanofi Aventis manufactures Lantus, the first insulin glargine approved in 2000. Basaglar is the following insulin to Lantus, developed by Eli Lilly. It was approved in 2015.

Lantus and Basaglar are typically injected under the skin (subcutaneously). 

Their physician determines each patient’s dosage.

There are two ways to administer Lantus: a prefilled pen injector (SoloStar) or a multi-dose vial injected with a syringe.

Unlike other drugs that come in multi-dose vials, Basaglar comes in a prefilled pen (KwikPen or Tempo Pen). Both products contain 100 units per milliliter (mL) of insulin glargine.

Diabetes type 1 and type 2 patients can take Basaglar and Lantus to cope with high blood sugar. Diabetic ketoacidosis cannot be treated using these drugs.

What Other Medications will Affect Basaglar KwikPen?

Blood sugar and Basaglar can be affected by many drugs. Insulin can be increased or decreased by medicine. You may also experience fewer hypoglycemic symptoms while taking some medications, making it more difficult to tell when your blood sugar is low. Provide your health care providers with a list of all medicines you use, new medications you begin taking, and any medication you stop taking. Supplements such as vitamins, over-the-counter drugs, and prescription medications are also included. Consult your physician regarding the remainder of your medications. The possibilities of interactions are not all listed here.

When Using Basaglar KwikPen, What Must I Avoid?

Be cautious when driving or engaging in hazardous activity for at least one week after you have used Basaglar KwikPen. It may affect your reaction time.

Check the label of your medication before injecting your insulin to prevent medication errors.

Alcohol and medicines containing alcohol should not be consumed. The medication you take for diabetes may be affected.